We have detected that you are using an Ad Blocker.
PracticeUpdate is free to end users but we rely on advertising to fund our site. Please consider supporting PracticeUpdate by whitelisting us in your ad blocker.
We have sent a message to the email address you have provided, . If this email is not correct, please update your settings with your correct address.
The email address you provided during registration, , does not appear to be valid. Please update your settings with a valid address before to continue using PracticeUpdate.
Please provide your AHPRA Number to ensure that you are given the correct level of access to our site.
Published in Oncology

Journal Scan / Research · February 27, 2020

Early Treatment With FCR vs Watch and Wait in Patients With Stage Binet A High-Risk CLL



Additional Info

Disclosure statements are available on the authors' profiles:

Early Treatment With FCR Versus Watch and Wait in Patients With Stage Binet A High-Risk Chronic Lymphocytic Leukemia (CLL): A Randomized Phase 3 Trial
Leukemia 2020 Feb 18;[EPub Ahead of Print], CD Herling, F Cymbalista, C Groß-Ophoff-Müller, J Bahlo, S Robrecht, P Langerbeins, AM Fink, O Al-Sawaf, R Busch, R Porcher, B Cazin, B Dreyfus, S Ibach, S Leprêtre, K Fischer, F Kaiser, B Eichhorst, CM Wentner, MA Hoechstetter, H Döhner, V Leblond, M Kneba, R Letestu, S Böttcher, S Stilgenbauer, M Hallek, V Levy

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.

Further Reading